查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012115

高強度聚焦超音波（HIFU）設備市場：導引、劑量方法、技術、產品、應用與終端用戶－2026-2032年全球市場預測

High Intensity Focused Ultrasound Devices Market by Guidance, Delivery Mode, Technology, Product, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年，高強度聚焦超音波（HIFU）設備市值為30.9億美元，預計2026年將達到34億美元。以10.81%的複合年成長率計算，預計到2032年將達到63.5億美元。

主要市場統計數據
基準年 2025 30.9億美元
預計年份：2026年 34億美元
預測年份 2032 63.5億美元
複合年成長率 (%) 10.81%

高強度聚焦超音波（HIFU）設備正從實驗平台發展成為跨多個學科領域的重要臨床工具。本文透過檢驗臨床需求、技術成熟度和監管變化之間的相互作用，概述了當前的生態系統。近年來，HIFU在非侵入性和微創工作流程中的有效性已引起臨床醫生的廣泛關注。此外，設備形式的多樣化也拓寬了其應用途徑。這些趨勢與日益複雜的醫保報銷環境交織在一起，積極的早期臨床結果正在推動保險公司與醫療機構的合作以及醫療機構的投資決策。

臨床應用的進展得益於多種因素的共同作用，包括影像引導技術的改進、操作流程的清晰化以及訓練有素的操作人員數量的增加。同時，製造商也在不斷改進設備的人體工學設計、能量傳輸方式以及與醫院資訊系統的整合，以提升處理能力和易用性。主要市場的監管機構也在調整其核准流程以適應新的治療方法，加上大量可靠證據的積累，這些因素共同加速了新療法的臨床應用。所有這些因素共同構成了一個充滿活力的環境，在這個環境中，策略的清晰度、營運的準備程度以及證據的一致性將決定哪些相關人員能夠從這項技術的未來潛力中持續受益。

轉變聚焦超音波治療的患者照護路徑、報銷框架、跨學科合作和技術環境。

在聚焦超音波治療領域，一場變革正在發生，它正在改變臨床路徑、競爭動態以及支付方和醫療服務提供者的預期。導航系統和治療計畫軟體的進步使得治療過程更加可預測和可重複，這些技術進步也推動了後續訓練模式和醫院工作流程的變革。隨著技術的普及應用，人們不僅要評估設備的有效性，還要評估其處理能力、治療總成本以及與現有影像系統的互通性。

評估 2025 年美國關稅對供應鏈、採購經濟、合作和設備可用性的累積影響。

美國2025年實施的關稅政策對整個聚焦超音波設備生態系統產生了累積影響，波及採購經濟性、供應鏈設計和國際合作模式。由於進口零件和組件的關稅增加，成本上升，設備製造商正在重新思考籌資策略，強調供應商多元化，並盡可能選擇近岸外包。雖然這些供應鏈調整可以降低單一供應商中斷的風險，但也增加了供應商認證和品管的過渡成本和複雜性。

細分洞察揭示了影像引導、傳輸方式、技術選擇、產品類型、臨床應用和最終用戶環境對部署的影響。

對細分市場的深入理解揭示了臨床、技術和商業性選擇如何在不同環境中造成不同的部署模式。本分析考察了磁振造影（MRI）引導和超音波引導兩種影像引導方法，這兩種方法導致了不同的臨床工作流程。 MRI導引手術可提供更優異的軟組織視覺化和溫度測量，但需要更高的資本投入和專用手術室。另一方面，超音波導引系統具有更廣泛的臨床應用和手術柔軟性。治療途徑可分為體外、組織間和腔內三種，每種途徑對應不同的臨床團隊、基礎設施需求和病患選擇標準。技術選擇也是差異因素，機械消融與熱消融相比，表現出不同的機械生物效應。即使在熱消融方法中，連續波和脈衝波模式也具有不同的安全性、能量管理特性和手術計畫要求。

區域性洞察，比較全球範圍內的促進因素、基礎設施發展、監管方法、報銷趨勢和臨床引入模式。

區域趨勢在決定聚焦超音波技術的應用、推廣和報銷方面發揮著至關重要的作用。在美洲，領先的醫療中心和發展相對迅速的私人保險市場支持了針對特定適應症的早期臨床應用。同時，強大的學術網路推動了多中心證據的累積。從早期採用者到醫療機構更廣泛應用的轉變需要臨床計劃者和採購決策者之間的合作，而這項轉變的時機往往取決於區域報銷環境。

競爭對手在產品平臺、策略聯盟、生產規模、監管進展和市場策略的趨勢。

聚焦超音波領域的企業格局呈現出競爭、合作和策略專業並存的特徵。主要企業正奉行兩大策略：提升核心技術能力和建立夥伴關係，以擴大臨床應用和服務範圍。投資重點通常包括改進治療計劃軟體、增強影像整合以及降低手術複雜性，旨在降低培訓門檻並擴大設備的應用環境。尤其值得注意的是，隨著設備從最初的臨床應用過渡到醫院的常規操作，生產規模和品管系統正日益成為企業競爭地位的關鍵因素。

為產業領導者提供策略建議，以加速臨床部署、最佳化供應鏈、調整報銷方式並優先考慮研發。

產業領導者應著重關注能夠將策略意圖轉化為可衡量成果的可執行優先事項。首先，將研發藍圖與臨床工作流程相契合，能夠提升醫療設備的功能，進而降低手術複雜性，並解決臨床醫師面臨的挑戰。投資於以使用者為中心的設計和整合影像工作流程通常能夠加速醫療機構的採納。其次，透過供應商多元化、本地組裝和模組化組件策略來增強供應鏈韌性，可以降低關稅風險並減少前置作業時間波動。

嚴謹的調查方法，說明了主要和次要資料、專家訪談、檢驗程序、細分邏輯和分析方法。

本分析的調查方法遵循嚴謹的一手和二手研究證據收集、專家檢驗以及高度透明的細分邏輯。一手研究活動包括對臨床意見領袖、採購負責人和技術主管進行結構化訪談，以了解他們對臨床工作流程、推廣障礙和採購優先事項的實際觀點。二手研究則利用同儕審查文獻、監管核准和公開資料，全面檢驗臨床結果、設備特性和治療路徑的演變。

該分析整合了策略意義、新興風險和機遇，以及領導者應採取的可操作步驟，以了解超音波。

總而言之，高強度聚焦超音波（HIFU）市場環境兼具臨床應用潛力與營運複雜性，需要採取嚴謹的策略行動。關鍵在於，要使設備功能與臨床工作流程相契合，展現以患者為中心的清晰療效，並以有意義的方式向採購和報銷利益相關人員體現價值。新興風險包括供應鏈中斷、不同司法管轄區的監管差異，以及需要強力的證據來獲得更廣泛支付方的支持。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 高強度聚焦超音波（HIFU）設備市場分類指南

  • 磁共振引導
  • 超音波引導

第9章 高強度聚焦超音波（HIFU）設備市場：以交付方式分類

  • 體外
  • 間質
  • 腔內

第10章 高強度聚焦超音波（HIFU）設備市場：依技術分類

  • 機械消融
  • 熱消融
    • 連續波
    • 脈搏波

第11章 高強度聚焦超音波（HIFU）設備市場：依產品分類

  • 可攜式的
  • 固定式

第12章 高強度聚焦超音波（HIFU）設備市場：依應用領域分類

  • 肝腫瘤
  • 胰臟腫瘤
  • 攝護腺癌
  • 子宮肌瘤

第13章：高強度聚焦超音波（HIFU）設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第14章：高強度聚焦超音波（HIFU）設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：高強度聚焦超音波（HIFU）設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：高強度聚焦超音波（HIFU）設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 美國高強度聚焦超音波（HIFU）設備市場

第18章 中國高強度聚焦超音波（HIFU）設備市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alpinion Medical Systems Co., Ltd.
  • Chongqing Haifu Medical Technology Co., Ltd.
  • EDAP TMS SA
  • FEBIO GmbH
  • FUS Instruments Inc.
  • ILJIN Holdings Co., Ltd.
  • Image Guided Therapy SAS
  • Insightec Ltd.
  • Mianyang Sonic Electronic Ltd.
  • Profound Medical Corp.
  • Shenzhen Weixianke Electronics Co., Ltd.
  • SonaCare Medical LLC
  • Storz Medical AG
  • Theraclion
Product Code: MRR-43539E5D36FD

The High Intensity Focused Ultrasound Devices Market was valued at USD 3.09 billion in 2025 and is projected to grow to USD 3.40 billion in 2026, with a CAGR of 10.81%, reaching USD 6.35 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.09 billion
Estimated Year [2026] USD 3.40 billion
Forecast Year [2032] USD 6.35 billion
CAGR (%) 10.81%

High intensity focused ultrasound devices have moved from experimental platforms to influential clinical tools across multiple specialties, and this introduction frames the current ecosystem by examining the interplay of clinical need, technological maturity and regulatory evolution. Recent years have seen proof points in noninvasive and minimally invasive workflows that have accelerated clinician interest, while a more diverse set of device form factors has broadened pathways to adoption. These trends intersect with an increasingly complex reimbursement landscape, where early positive clinical outcomes are catalyzing payer engagement and institutional investment decisions.

Clinical momentum is supported by converging drivers: improved imaging guidance, clearer procedural protocols, and a growing cadre of trained operators. Concurrently, manufacturers are refining device ergonomics, energy delivery modalities and integration with hospital information systems to improve throughput and ease of use. Regulatory authorities in key markets have also adapted submission pathways to accommodate novel therapeutic modalities, which reduces time to clinical availability when paired with robust evidence generation. Taken together, these forces create a dynamic environment in which strategic clarity, operational readiness and evidence alignment will determine which stakeholders sustainably benefit from the technology's promise.

Transformations reshaping patient pathways, reimbursement frameworks, cross-disciplinary collaborations, and technological landscape in focused ultrasound therapies

The focused ultrasound landscape is undergoing transformative shifts that are altering clinical pathways, competitive dynamics and the expectations of payers and providers. Advances in guidance systems and treatment planning software are enabling more predictable, reproducible procedures, and this technical progress drives downstream changes in training models and hospital workflows. As adoption increases, devices are being evaluated not only on efficacy but also on throughput, total cost of procedure and interoperability with existing imaging suites.

In parallel, reimbursement frameworks are moving from experimental coverage toward more structured pathways in certain indications, shifting economic incentives and encouraging larger-scale deployments. Cross-disciplinary collaborations between radiology, oncology and surgical specialties are fostering hybrid care models that incorporate focused ultrasound as an adjunct or alternative to surgery or systemic therapy. Commercial strategies are responding with diversified go-to-market approaches that combine direct hospital partnerships, specialty clinic engagement and expanded service offerings. The outcome is a market that is more nuanced: success favors organizations that align R&D priorities with real-world clinical needs and that can demonstrate operational and economic value across a spectrum of care settings.

Assessment of the cumulative consequences of United States tariffs in 2025 on supply chains, procurement economics, collaboration and device accessibility

The introduction of United States tariffs in 2025 has produced cumulative effects across the focused ultrasound device ecosystem by influencing procurement economics, supply chain design and international collaboration patterns. Tariff-induced cost increases on imported components and subassemblies have prompted device manufacturers to re-evaluate sourcing strategies, emphasizing supplier diversification and nearshoring where feasible. These supply chain adaptations reduce exposure to single-source disruptions but also introduce transitional costs and complexity in vendor qualification and quality control.

Procurement teams at hospitals and specialty clinics have responded by tightening vendor evaluations and seeking clearer total-cost-of-ownership calculations, which now must account for tariff-inflated capital and consumable expenses. For companies that relied on long-standing cross-border manufacturing partnerships, tariffs have accelerated decisions to localize assembly or to renegotiate commercial terms with distributors. The regulatory and clinical trial landscape has also felt indirect effects: higher operational costs can slow enrollment incentives or increase the cost of running multi-center studies, which in turn affects evidence generation timelines.

Finally, the tariffs have incentivized more rigorous scenario planning among executives, who are balancing short-term margin protection tactics with longer-term investments in supply chain resilience and cost engineering. The net impact is a re-prioritization of strategic focus toward operational agility, supplier risk management and clearer communication of value to procurement stakeholders facing stretched capital budgets.

Segmentation insights revealing how imaging guidance, delivery mode, technology choice, product type, clinical application and end-user setting affect adoption

A nuanced understanding of segmentation reveals how clinical, technical and commercial choices drive differentiated adoption patterns across settings. This analysis considers imaging guidance across MRI Guided and Ultrasound Guided approaches, which create distinct clinical workflows: MRI-guided procedures offer superior soft-tissue visualization and thermometry yet demand higher capital intensity and specialized suites, while ultrasound-guided systems enable broader point-of-care use and procedural flexibility. Delivery mode is differentiated by Extracorporeal, Interstitial and Intracavitary approaches, and each mode aligns with different clinical teams, infrastructure requirements and patient selection criteria. Technology selection is another axis of variation, with Mechanical Ablation offering distinct mechanobiological effects compared with Thermal Ablation; within thermal approaches, the continuous wave and pulsed wave modalities present divergent safety profiles, energy management characteristics and procedural planning needs.

Product form factors range from Portable to Stationary devices, and that distinction has profound implications for deployment: portable systems facilitate ambulatory and outpatient settings, whereas stationary platforms are optimized for high-volume hospital suites with advanced imaging integration. Clinical applications-spanning Liver Tumor, Pancreatic Tumor, Prostate Cancer and Uterine Fibroids-each have unique evidence requirements, referral pathways and reimbursement considerations, and the pace of clinical adoption varies accordingly. End-user segmentation includes Ambulatory Surgical Centers, Hospitals and Specialty Clinics, and these settings differ in capital purchasing cycles, staffing models and procedural throughput expectations. Understanding how these segmentation axes intersect enables more targeted product development, evidence generation and commercialization strategies that match technology attributes to clinical and operational realities.

Regional insights comparing drivers, infrastructure readiness, regulatory approaches, reimbursement dynamics and clinical adoption patterns across world regions

Regional dynamics play a decisive role in shaping how focused ultrasound technologies are adopted, scaled and reimbursed. In the Americas, leading centers of excellence and a relatively fast-moving private payer market have supported early clinical uptake in selected indications, while robust academic networks have driven multicenter evidence generation. Transitioning from early adopters to broader institutional adoption requires alignment between clinical champions and procurement decision-makers, and the regional reimbursement environment often determines the timing of that transition.

Europe, Middle East & Africa presents a more heterogeneous regulatory and reimbursement landscape, where national-level decision-making and varied healthcare delivery models require localized engagement strategies. In some jurisdictions, centralized health technology assessment processes raise the bar for evidence, while in others niche reimbursement pathways enable targeted deployment. Manufacturers must therefore calibrate clinical and economic dossiers to account for national differences in payer expectations and hospital financing.

Across Asia-Pacific, infrastructure investments and rising demand for minimally invasive treatments are creating sizable opportunities, yet market entry strategies must account for diverse regulatory regimes, varying imaging adoption and differing hospital procurement practices. In all regions, successful expansion hinges on demonstrating clear clinical value, operational fit and sustainable service models that match local healthcare priorities and resource constraints.

Competitive company intelligence on product pipelines, strategic partnerships, manufacturing scale, regulatory progress and go-to-market positioning

Company-level dynamics in the focused ultrasound sector are characterized by a blend of competition, collaboration and strategic specialization. Leading developers are pursuing dual strategies: advancing core technology capabilities while forming partnerships that expand clinical reach and service capacity. Investment focus commonly includes improving treatment planning software, enhancing imaging integration and reducing per-procedure complexity to lower training thresholds and expand usable settings. Manufacturing scale and quality systems are increasingly central to competitive positioning, particularly as devices move from early clinical use into routine hospital operations.

Strategic alliances with academic centers and clinical networks remain a critical tactic for accelerating evidence generation and establishing centers of excellence. At the same time, commercial differentiation often hinges on service models that bundle training, maintenance and outcome support, addressing purchaser concerns about operational risk. Regulatory progress and clearances are leveraged to gain market access, but companies also emphasize post-market evidence collection and real-world data initiatives to support reimbursement conversations. For smaller innovators, partnering with established distributors or device platforms is a pragmatic route to market, while larger firms pursue selective acquisitions to fill technology or geographic gaps. The competitive landscape will favor organizations that integrate clinical validation with scalable manufacturing and pragmatic commercialization models.

Strategic recommendations enabling industry leaders to accelerate clinical adoption, optimize supply chains, align reimbursement approaches and prioritize R&D

Industry leaders should concentrate on a set of actionable priorities that translate strategic intent into measurable outcomes. First, aligning R&D roadmaps with clinical workflows will ensure that device features reduce procedural complexity and address clinician pain points; investments in user-centered design and integrated imaging workflows typically yield faster institutional adoption. Second, strengthening supply chain resilience through supplier diversification, localized assembly and modular component strategies can mitigate tariff exposure and reduce lead-time volatility.

Third, evidence strategies should be tiered: focused, indication-specific clinical programs that demonstrate meaningful patient outcomes must be complemented by pragmatic real-world evidence initiatives to support reimbursement discussions. Fourth, commercial models need to be tailored by end-user; ambulatory surgical centers, hospitals and specialty clinics each require distinct pricing, training and service packages to align with purchasing behaviors. Finally, strategic partnerships with payers, academic collaborators and systems integrators can accelerate market access and broaden referral networks. Executives who operationalize these priorities-by setting clear metrics, allocating cross-functional resources and maintaining agile governance-will be better positioned to convert technological promise into durable clinical and commercial impact.

Rigorous research methodology describing primary and secondary data, expert interviews, validation steps, segmentation logic and analytical techniques

The research methodology underpinning this analysis adheres to rigorous primary and secondary evidence collection, expert validation and transparent segmentation logic. Primary research activities included structured interviews with clinical opinion leaders, procurement professionals and technology executives to capture frontline perspectives on clinical workflows, adoption barriers and purchasing priorities. Secondary research drew on peer-reviewed literature, regulatory clearances and public filings to triangulate clinical outcomes, device characteristics and pathway evolution.

Validation steps incorporated cross-checks between interview insights and published data, while analytical techniques combined qualitative thematic synthesis with structured segmentation frameworks to surface actionable conclusions. The segmentation logic maps imaging guidance options, delivery modes, technological categories, product form factors, clinical applications and end-user settings to observed adoption behaviors and operational constraints. Throughout the process, quality controls ensured that assumptions were documented, sources were traceable and interpretations were anchored to empirical evidence.

This methodological approach balances depth of clinical insight with operational rigor to provide stakeholders a dependable foundation for strategic decisions and follow-on analysis.

Conclusion synthesizing strategic takeaways, emergent risks and opportunities, and actions leaders should pursue to navigate the focused ultrasound landscape

In synthesis, the high intensity focused ultrasound landscape presents a compelling mix of clinical promise and operational complexity that requires disciplined strategic action. Key takeaways emphasize the importance of aligning device capabilities with clinical workflows, demonstrating clear patient-centered outcomes and packaging value in ways that are meaningful to procurement and reimbursement stakeholders. Emergent risks include supply chain disruptions, regulatory variability across jurisdictions and the need for robust evidence to unlock wider payer support.

Opportunities are concentrated where technology attributes reduce procedural burden, expand the settings of care and provide measurable improvements in patient experience or health-system efficiency. Organizations that can integrate clinical validation, scalable manufacturing and pragmatic commercialization will capture the most durable advantage. Leaders should adopt a proactive posture-investing in supply chain resilience, tailoring go-to-market models by end-user setting, and cultivating payer and clinical partnerships that support broader adoption.

Ultimately, clear strategic focus, evidence-aligned execution and operational adaptability will determine which stakeholders successfully convert innovation into sustained clinical and commercial impact in this evolving therapeutic area.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. High Intensity Focused Ultrasound Devices Market, by Guidance

  • 8.1. MRI Guided
  • 8.2. Ultrasound Guided

9. High Intensity Focused Ultrasound Devices Market, by Delivery Mode

  • 9.1. Extracorporeal
  • 9.2. Interstitial
  • 9.3. Intracavitary

10. High Intensity Focused Ultrasound Devices Market, by Technology

  • 10.1. Mechanical Ablation
  • 10.2. Thermal Ablation
    • 10.2.1. Continuous Wave
    • 10.2.2. Pulsed Wave

11. High Intensity Focused Ultrasound Devices Market, by Product

  • 11.1. Portable
  • 11.2. Stationary

12. High Intensity Focused Ultrasound Devices Market, by Application

  • 12.1. Liver Tumor
  • 12.2. Pancreatic Tumor
  • 12.3. Prostate Cancer
  • 12.4. Uterine Fibroids

13. High Intensity Focused Ultrasound Devices Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals
  • 13.3. Specialty Clinics

14. High Intensity Focused Ultrasound Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. High Intensity Focused Ultrasound Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. High Intensity Focused Ultrasound Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States High Intensity Focused Ultrasound Devices Market

18. China High Intensity Focused Ultrasound Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Alpinion Medical Systems Co., Ltd.
  • 19.6. Chongqing Haifu Medical Technology Co., Ltd.
  • 19.7. EDAP TMS S.A.
  • 19.8. FEBIO GmbH
  • 19.9. FUS Instruments Inc.
  • 19.10. ILJIN Holdings Co., Ltd.
  • 19.11. Image Guided Therapy SAS
  • 19.12. Insightec Ltd.
  • 19.13. Mianyang Sonic Electronic Ltd.
  • 19.14. Profound Medical Corp.
  • 19.15. Shenzhen Weixianke Electronics Co., Ltd.
  • 19.16. SonaCare Medical LLC
  • 19.17. Storz Medical AG
  • 19.18. Theraclion

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 140. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 143. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 166. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 167. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 172. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 174. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 175. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)